ioNano 46™ Nebulising Liquid – 200 ml

ioNano 46 200ml

R193.55

Silverlab’s 200ml ioNano 46™️ Nebulising Liquid is specifically formulated to target respiratory ailments, including symptoms such as cough, shortness of breath, hypoxia (oxygen deficiency) and a tight chest.

Only available online.

NAPPI:

3002090001

Product information

Silverlab’s ioNano 46TM Nebulising Liquid (25 ppm) is specifically formulated for respiratory care and support, including assistance with symptoms such as cough, shortness of breath and a tight chest.

Each nebulised drop contains billions of positively charged ionic+ silver particles, which seek and eliminate harmful microorganisms. For optimal outcome, nebulising the nano-particle solution facilitates instant absorption and bioavailability to the affected area, targeting signs and symptoms that may include colds, flu, lung infections, sinus infections, and nasal congestion.

Use in combination with Silverlab’s Nasal Spray for extra support against respiratory conditions.

USES:

Silverlab ioNano 46TM may be used as an antimicrobial (anti-viral, anti-bacterial and anti-fungal) agent to assist with various conditions. It also exhibits anti-inflammatory properties. Silverlab ioNano 46TM serves as a nebulising liquid and may alleviate respiratory symptoms such as a cough, shortness of breath or tight chest. It may also assist by supporting the immune system, and may therefore provide a first-line of defence.

In various laboratory tests, Colloidal Silver displayed anti-inflammatory, antibacterial, antiviral, antifungal and antimycotic properties. Because Colloidal Silver is natural, and when using the recommended dosages, has no known toxic side-effects. This renders Colloidal Silver as an agent with a favourable safety profile.

DOSAGE AND DIRECTIONS FOR USE:

If you have respiratory symptoms:
Adults: Days 1 & 2: Nebulise with 5 ml every hour until symptoms subside significantly or resolve, (generally within 2-12 doses).
Symptoms may include cough, shortness of breath or tight chest, which may be accompanied with a headache or generalised weakness.
If symptoms are not improving or are worsening, please consult your doctor.
Day 3 onwards: Nebulise with 5 ml, 2 to 3 times a day until there is complete resolution of symptoms (up to 14 days).
Children: Nebulising should be done under the prescription or supervision of a doctor.
Children over 12: 5 ml, as per Adults above or as prescribed.
Children above 5 years: Nebulise with 2,5 ml as per Adults above, or as prescribed.

  • To avoid possible dizziness / light-headedness due to hyperventilation, please breathe normally with slow deep breaths while nebulising.
  • Best results are obtained when nebulising while in an upright position.
  • Alternate between inhaling through the nose and then inhaling through the mouth if possible.

Use undiluted.

POSSIBLE SIDE EFFECTS:

Adults should not ingest and/or inhale more than 396 litres of 25 ppm ionic+ colloidal silver in their lifetime, an average of 5,6 litres per year, to prevent the possibility of Argyria developing. Argyria is a slight discolouration/greying of the skin. The first signs are seen on the nail beds just above the moon of the nail. If this becomes blue, discontinue use and contact the telephone number below. Argyria is rare, and is a cosmetic effect only and is in no way detrimental to one’s health.

KNOWN SYMPTOMS OF OVER DOSAGE AND PARTICULARS OF ITS TREATMENT:

None known. Treatment of over dosage is symptomatic and supportive.

ACTIVE SUBSTANCES:

Each 5 ml of ioNano 46™ (25 ppm) Nebulising Liquid contains 125 mcg of electrically isolated silver nano ions+ .

The other ingredients are: Deionised purified water.

WHY NEBULISE?

For optimal outcome, nebulising the nano-particle silver solution facilitates instant absorption and assimilation to the aliment.

WHY SILVERLAB?

Silverlab is the undisputed leader of ionic+ Colloidal Silver in South Africa. Their product range is trusted by millions for over 20-years and well-known for its favourable safety profile. Silverlab’s ioNano 46TM Nebulising Liquid represents the ultimate refinement of the ionic+ nanoparticle Colloidal Silver category, offering the optimum concentration and particle size for respiratory ailments.

DOES COLLOIDAL SILVER KILL VIRUSES?

The ionic portion of Silverlab’s silver has antimicrobial properties. This is a well-documented scientific fact. Dr Wesley Alexander say ‘Silver has been used for at least six millennia to prevent microbial infections. It has been effective against almost all organisms tested and has been used to treat numerous infections and non-infectious conditions, sometimes with striking success.’ (Alexander, 2009. Surgical Infections. Volume 10, Number 3, 2009).

HOW SAFE IS IONIC⁺ COLLOIDAL SILVER?

Colloidal Silver is known to have a favourable safety profile. (1, 2, 3, 4, 5, 6, 7, 8)

  1. Dean W, Mitchell M, Lugo VW, South Reduction of Viral Load in AIDS Patients with Intravenous Mild silver Protein three Case Reports. Clinical Practice of Alternative Medicine, Spring 2001; 2(1):48-53.
  2. Becker R, Spadaro J. Treatment of Orthopaedic Infections with Electrically Generated Silver Ions. The Journal of bone and Joint Surgery. Oct 1978:60-A (7); 871-881.
  3. Becker RO, Spadaro JA, Marino AA. Clinical Experiences with Low Intensity Direct Current Stimulation of Bone Growth. ClinOrthop. 1977 124:75-83.
  4. Berger TJ, Spadaro SE, Chapin, Becker RO. Electrically Generated silver Ions: Quantitative Effects on Bacterial and Mammalian Cells. Antimicrobial Agents and Chemotherapy. Feb 1976:357-358.
  5. Duhamel B. Electric metal colloids and their therapeutically applications. Lancet. Jan 13; 1912:89-90.
  6. Rentz E. Viral Pathogens and Svere Acute Respiratory Syndrome: Oligodynamic Ag+ for direct Immune Intervention. Journal of Nutritional & Environmental Medicine, June 2003; 13(2):109-118.
  7. Sanderson-Wells. A Case of Puerperal Septicaemia Successfully Treated with Intravenous Injections of Collosol Argentum. The Lancet, Feb 16, 1916:258.
  8. Wysor M. Orally-Administered Silver Sulfadiazine; Chemotherapy and Toxicology in CF-1 Mice: Plasmodium berghei (Malaria) and Pseudomonas aeruginosa. Chemotherapy 1975;21:302-310

Downloads

ioNano 46TM LEAFLET